kneat.com, inc., a leader in digitizing and automating validation and quality processes, is pleased to announce that it has signed a partnership agreement with leading international technology group, Körber, and its pharma consulting experts from the Körber Pharma Consulting GmbH. The agreement expands Kneat’s go-to-market by enabling Körber to resell and implement Kneat Gx, and offer managed services to its customers using the Kneat Gx platform. Körber’s expertise in manufacturing, supply chain and technology for the life sciences industry positions it well to leverage Kneat’s platform and advance the industry on its Pharma 4.0 journey.
Körber is headquartered in Germany with over 12,000 employees and operations in more than 100 locations worldwide, and its Business Area Pharma is an established technology leader in the field of life sciences technologies. With more than 125 years of life sciences expertise, Körber’s customers include some of the largest biopharmaceutical companies in the world.
Körber is a leader in the life sciences regulated industry, supporting customers not only in the areas of production, packaging, and inspection but also in their implementation of software for the entire manufacturing process. Körber initially plans to use Kneat Gx for Computer System Validation (CSV). Leveraging Kneat’s CSV capabilities will complement Körber’s market-leading Manufacturing Execution System (MES) Suite PAS-X, which controls, monitors and documents processes digitally in real time throughout the manufacturing cycle. Körber also plans to use Kneat for many other validation processes including Process, Equipment and Commissioning and Qualification.
Also Read: Daicel Arbor Biosciences launches new myTXTL® kits to accelerate protein expression
“We’re delighted to add Körber to expand our partners. Körber and Kneat share a common goal, which is to help life sciences companies to develop, manufacture and deliver their products to their patients to the highest safety standard. We look forward to working with Körber to accelerate this value to our customers,” said Eddie Ryan, co-founder and CEO of Kneat.
“At Körber we have built our leadership in the life sciences space by helping companies reduce error rates and manufacturing costs, shorten time to market, and increase efficiency. Incorporating Kneat Gx brings this same level of excellence in validation to our customers,” stated Jörg Erdmann, CEO Consulting, Körber Business Area Pharma.
SOURCE: GlobeNewswire